Evidence map›Paper›PMID 20479963›Full record

ReviewMarine drugs2010

Chitosan in plant protection.

Abdelbasset El Hadrami, Lorne R Adam, Ismail El Hadrami, Fouad Daayf

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 740 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Non- Conventional Agents Enhance Sweet Pepper (Global challenges (Hoboken, NJ) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Induction of Bioactive Secondary Metabolites inPlant-environment interactions (Hoboken, N.J.) · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abdelbasset El HadramiUniversity of Manitoba, Department of Plant Science, 222, Agriculture Building, Winnipeg, Manitoba, R3T 2N2, Canada. elhadram@cc.umanitoba.ca
Lorne R Adam
Ismail El Hadrami
Fouad Daayf
University of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitin and chitosan are naturally-occurring compounds that have potential in agriculture with regard to controlling plant diseases. These molecules were shown to display toxicity and inhibit fungal growth and development. They were reported to be active against viruses, bacteria and other pests. Fragments from chitin and chitosan are known to have eliciting activities leading to a variety of defense responses in host plants in response to microbial infections, including the accumulation of phytoalexins, pathogen-related (PR) proteins and proteinase inhibitors, lignin synthesis, and callose formation. Based on these and other proprieties that help strengthen host plant defenses, interest has been growing in using them in agricultural systems to reduce the negative impact of diseases on yield and quality of crops. This review recapitulates the properties and uses of chitin, chitosan, and their derivatives, and will focus on their applications and mechanisms of action during plant-pathogen interactions.

Indexed as

AgricultureAnti-Infective AgentsChitinChitosanCrops, AgriculturalPlant DiseasesPlantsAnti-Infective AgentsChitinChitosanbiocidal activitybiological controlchitinchitosanplant defensesresistance

Identifiers

PMID20479963
PMCPMC2866471
OpenAlexW2064011765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.